BSE filing, NSE: MANAPPURAM. Summary written from the filing by ALFA Finder's alert engine.
Manappuram Finance Ltd: key numbers
- Share price
- ₹288.75
- Market cap
- ₹24,441 Cr
- Revenue (annual)
- ₹9,509 Cr
- Net profit (annual)
- ₹1,003 Cr
- P/E (TTM)
- 16.9×Sector 19.7×
- Promoter holding
- 41.66%+0.00% QoQ
- FII holding
- 21.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manappuram Finance Ltd
All →Manappuram Finance Debt & Borrowing: ₹250 Cr
Manappuram Finance Ltd redeemed its Rs.250 Crore Commercial Paper at maturity. Full principal was repaid on October 23, 2026.
- Value
- ₹250.0 Cr
Manappuram Finance Other Announcement
Manappuram Finance Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026. This is a periodic compliance disclosure.
Manappuram Finance Debt & Borrowing: ₹375 Cr
Manappuram Finance has successfully redeemed Commercial Paper worth ₹375 Crore upon maturity on September 16, 2026. The outstanding amount is now zero.
- Value
- ₹375.0 Cr
Manappuram Finance Debt & Borrowing: ₹250 Cr
Manappuram Finance has completed the redemption of listed Commercial Papers worth ₹250 Crore on their maturity date of September 15, 2026.
- Value
- ₹250.0 Cr
Manappuram Finance Management Change
Manappuram Finance informed the exchange that two senior business heads resigned for personal reasons. The departures take effect from 15 and 16 September 2026.
Manappuram Finance Share Pledge
Promoter V.P. Nandakumar created a pledge on 17.18 lakh shares of Manappuram Finance, valued at ₹55 Crore.
- Value
- ₹55.00 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.